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Available online 27 April 2016Mesenchymal stem cell (MSC)-derived exosomes have diverse functions in regulating wound healing and in-
ﬂammation; however, the molecular mechanism of human umbilical cord MSC (hUCMSC)-derived exosomes
in regulating burn-induced inﬂammation is not well understood. We found that burn injury signiﬁcantly in-
creased the inﬂammatory reaction of rats or macrophages exposed to lipopolysaccharide (LPS), increased
tumor necrosis factor α (TNF-α) and interleukin-1β (IL-1β) levels and decreased IL-10 levels. hUCMSC-
exosome administration successfully reversed this reaction. Further studies showed that miR-181c in the
exosomes played a pivotal role in regulating inﬂammation. Compared to control hUCMSC-exosomes, hUCMSC-
exosomes overexpressing miR-181c more effectively suppressed the TLR4 signaling pathway and alleviated in-
ﬂammation in burned rats. Administration of miR-181c-expressing hUCMSC-exosomes or TLR4 knockdown sig-
niﬁcantly reduced LPS-induced TLR4 expression by macrophages and the inﬂammatory reaction. In summary,
miR-181c expression in hUCMSC-exosomes reduces burn-induced inﬂammation by downregulating the TLR4
signaling pathway.
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Inﬂammation1. Introduction
Various source-derived mesenchymal stem cells (MSCs) show
promise as cell-based therapies. They have emerged as a productive,
feasible, accepted, and universal source by various methods of MSC iso-
lation (Karahuseyinoglu et al., 2007; Frausin et al., 2015). Previous stud-
ies have shown that human umbilical cord mesenchymal stem cells
(hUCMSCs) can be applied to alleviate inﬂammatory diseases, such as
colitis, pancreatitis, sepsis and focal cerebral ischemia (Liang et al.,
2011; Li et al., 2012; Lin et al., 2012).
Recent studies have shown that themajority of the therapeutic ben-
eﬁts of MSCs result from the release of paracrine soluble factors (Liang
et al., 2014). Exosomes are microvesicles secreted from the endosomal
membrane and have been shown to act as regulators of cell-cell com-
munication (E.L. et al., 2013; Gangoda et al., 2015). A rapidly increasing
number of reports have suggested that MSC-derived exosomes are a
very attractive candidate for cell therapy applications in several diseases
(Katsuda et al., 2013; Akyurekli et al., 2015; Rani et al., 2015). Exosomes
range in size from10 to 100 nmand contain proteins,mRNAandmiRNAtic Surgery, The First Afﬁliated
idian District, Beijing, 100048,
. This is an open access article undermolecules, which can be functionally transferred between cells and af-
fect protein expression in target cells (Tetta et al., 2013; Colombo
et al., 2014; Turturici et al., 2014).
MiRNAs are a class of endogenous small noncoding RNAs responsi-
ble for post-transcriptional regulation of gene expression that have
been implicated in the pathogenesis of many diseases (Lee et al.,
1993; Rebane and Akdis, 2013). Emerging evidence has suggested that
miRNAs reduce inﬂammation by regulating target proteins in inﬂam-
matory signaling pathways (Cardoso et al., 2015; Chiu and Wu, 2015).
miR-181c has been suggested as an essential therapeutic in anti-
inﬂammation treatment (Takahashi et al., 2012). Previous studies
have demonstrated that miR-181c plays a potential role in regulating
TNF-a expression after ischemia-mediated neuronal injury and hypoxia
microglial activation-induced neuroinﬂammation (Zhang et al., 2012;
Hutchison et al., 2013). We previously comparedmiRNA expression be-
tween severe burn rats and sham rats by miRNA array and found that
miR-181c was deregulated in early stage burn rats (Haijun et al., 2015).
Reports from our laboratory have demonstrated that hUCMSCs re-
markably decreased the number of inﬂammatory cells and TNF-a, IL-1,
IL-6 levels and increased IL-10 levels in wounds of severe burn rats
(Liu et al., 2014). However, the mechanisms underlying the therapeutic
effects of hUCMSCs in excessive inﬂammation of severe burns are un-
clear. We hypothesized that miRNAs transferred by hUCMSC-
exosomes suppress the severe burn-induced inﬂammatory response
via speciﬁc gene expression regulated by miRNAs.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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by miRNA array to identify miRNAs signiﬁcantly enriched in hUCMSC-
exosomes between severe burn rat and sham rat. We focused on the
role of hUCMSC-exosomes in severe burn-induced excessive inﬂamma-
tion in vitro and in vivo, and we performed miR-181c gain of function
experiments to increase the miR-181c level in hUCMSC-exosomes to
test whether miR-181c suppressed NF-κB activation and downstream
proinﬂammatory factors by downregulating the TLR4 signaling
pathway.
2. Materials and Methods
2.1. Exosome Isolation (Salama et al., 2014)
Exosomes were isolated and puriﬁed from the supernatant of
hUCMSCs and hSFCs. Brieﬂy, hUCMSCs (catalog #7530) and hSFCs (cat-
alog #2320) were purchased from Sciencell company (Carlsbad, CA,
USA) and the cells at passages 3–8 were cultured in serum-free medi-
um, supplemented with 10% FBS and 1% penicillin/streptomycin at
37 °C in a humidiﬁed atmosphere of 5% CO2 for 48 h before harvesting
the medium. Conditioned medium was centrifuged at 2000g for
10 min at 4 °C to remove cell debris and then passed through a
0.22 μm ﬁlter. The cleared supernatant was transferred to a new glass
tube and kept on ice. The supernatant was mixed with A/B/C solution
(101Bio company, CA, USA) (2 ml supernatant with 0.75 ml A/B/CFig. 1. Characterization of exosomes derived from human umbilical cord mesenchymal stem ce
using a 101Bio Exosome Kit. (A). Identiﬁcation of themainmorphological characteristics of hUC
(B). Dynamic light scattering (DLS) number distributionmeasurement of hUCMSC-exosomes ha
Genechip analysis. (D). The markers of exosomes are detected using western blot assay.solution) in a new tube, vigorously vortexed for 30 s, and incubated at
4 °C for 30 min. The mixture separated into 2 layers, and the top layer
was removed and discarded. The bottom layer was transferred to a
microcentrifuge tube and spun at 5000g for 3 min. The middle ﬂuff
layer was transferred to a new microcentrifuge tube and was spun at
5000g for 3min. The capwas left open to air dry for 10min at room tem-
perature. A total of 4× volume of 1× PBS was added to the tube and pi-
petted vigorously. The tube was placed on a horizontal shaker for
15 min at high speed, then spun at 5000g for 5 min. The supernatant
was carefully transferred to a PureExo® Column (101Bio company,
CA, USA) and spun at 1000g for 5 min. The ﬂow-through contained
the isolated pure exosome fraction suspended in PBS (Thery et al.,
2006).
2.2. Transmission Electron Microscopy Analysis of hUCMSC-exosomes
Three drops of fresh exosome suspension (10 μl each)were deposit-
ed on clean paraﬁlm. Formvar-carbon coated EM grids were ﬂoated
onto the dropwith the coated side facing the suspension. The gridmem-
branes were allowed to absorb exosomes for 15 min in a dry environ-
ment. Wash buffer was used to clean the grid twice on paraﬁlm, and
the grids were transferred (coated side down) to wash buffer drops.
The grid was incubated in wash buffer drops for 1 min. A 10 μl drop of
EM solution was deposited onto clean paraﬁlm. The grids were
transferred (coated side down) to the drop and incubated for 15 min,lls (hUCMSCs). hUCMSC-exosomes were isolated and puriﬁed from hUCMSC supernatant
MSC-exosomes by transmission electronmicroscopy images, Scale bar= 100 nm/200 nm.
ve a single peak (~60nm) diameter. (C). RNA expression proﬁles of hUCMSC-exosomes by
74 X. Li et al. / EBioMedicine 8 (2016) 72–82then washed twice with wash buffer. The grids were transferred to
ﬁlter paper with the coated side up and allowed to air dry at room tem-
perature for 10 min. Exosomes were examined on a HITACHI H-7650
transmission electron microscope (HITACHI company, Japan) at 80 kv.Fig. 2. hUCMSC-exosomes alleviate the inﬂammatory response in severe burn rats. 30% TBSA
exosomes, hSFC-exosomes or PBS via tail vein injection. Rats were sacriﬁced, and serum and s
detected at the indicated times in sham and burn rats treated with hUCMSC-exosomes, hSFC-
analysis of serum TNF-α, IL-1β and IL-10 levels in sham and burn rats treated with hUCMSC-
n = 6 for hUCMSC-exosome treated, n = 6 for hSFC-exosome treated, and n = 5 for PBS tre
CD68 staining in cutaneous wounds from different groups were examined by immunohistoche2.3. NanoSight Dynamic Light Scattering Analysis of hUCMSC-exosomes
A total of 10ml supernatant from cells cultured for 48 h was used to
isolate hUCMSC-exosomes using the PureExo® Exosome Isolation kitfull-thickness burn and sham rats were used, and burn rats were treated with hUCMSC-
kin tissues were collected at different time points after treatment. (A). Total WBCs were
exosomes or PBS. Data are shown as mean ± SD, n = 6 for each treatment. (B–D). ELISA
exosomes, hSFC-exosomes or PBS at the indicated times. Data are shown as mean ± SD,
ated. (E). Representative histological micrographs analysis (HE stain) and positive MPO,
mistry at 24 h. And the quantitive assay is done using Image Pro Plus software.
75X. Li et al. / EBioMedicine 8 (2016) 72–82(101Bio, California, USA). The exosome pellet was re-suspended in
100 μl PBS and further analyzed by NanoSight dynamic light scattering
(632.8 nm laser) using a BI 200SM Research Goniometer System
(Brookhaven Instruments Corporation, Holtsville, NY, USA).
2.4. MicroRNA Array Analysis of hUCMSC-exosomes
Total RNA was extracted from hUCMSC-exosomes using an exosomal
RNA extraction kit (101Bio, CA, USA) according to the manufacturer's in-
structions. This protocol effectively recovers both mRNA and miRNA.
Array experiments were performed by Genechem Corp. (Shanghai,
China) as described on the company's website (http://www.genechem.
com.cn) and in previous reports using an miRNA array (GeneChip
miRNA Array; Affymetrix Inc., Santa Clara, CA, USA), which contains
6153 probe sets from the miRNAs registered in the Sanger miRBase
miRNA database (release 21.0; http://www.mirbase.org/; accessed Jun
2014). miRNA expression levels (normalized total reads) in hUCMSC-
exosomes and fold-change enrichment were calculated.
2.5. miR-181c Pre-treatment of hUCMSC-exosomes
hUCMSCs were cultured in six-well plates andwere pretreated with
siPORTNeoFX containing 100 nMmiR-181cmimics or Negative Control
(Genechem Corp., Shanghai, China) at 80% cell conﬂuence for 24 h. The
medium was replaced, and the cells were cultured for an additional
48 h. The medium was collected for exosome isolation.Fig. 3. hUCMSC-exosomes decreased TLR4 protein level and increased relativemiR-181c expres
were used to further analyze the potential molecularmechanism. (A).Western blot assay for TL
of rats from different groups. And the relative protein level of TLR4 is measured by Image J softw
rats from different groups at the indicated times. Data are shown as mean± SD, n = 6 for each
from severe burn rats and normal skin of sham rats. (D). Quantitative analysis of relative miR-1
exosomes, hSFC-exosomes or PBS at the indicated times. Data are shown asmean± SD, n= 6 f
exosomes were detected by quantitative RT-PCR. Data are shown as mean ± SD, n = 5 for eac2.6. Severe Burn Rat Model and hUCMSC-exosome Administration
All rat studieswere performed in accordancewith theNational Insti-
tutes of Health guide for the care and use of guidelines and approved by
the Institutional Animal Care and Use Committee at the First Afﬁliated
Hospital of PLA General Hospital. Six-week-old adult male SD rats
(weighing 200 ± 20 g) purchased from Academy of Military Medical
Sciences Laboratory Animal Center were used for all experiments. A
rat model of third degree 30% total body surface area (TBSA) and full-
thickness burn wound was established as described previously. Brieﬂy,
rats were anesthetized by intraperitoneal injection of 300 mg/kg
Avertin (20 mg/ml) (2,2,2-tribro-moethanol, Sigma, USA), and the dor-
sal hair was completely removed. The backside of the rats was placed in
hot water (94 °C) for 12 s, which caused a 30% TBSA full-thickness burn.
Balanced salt solution (40 mg/kg) was immediately administered to
prevent shock. The wound was treated with a 1% tincture of iodine
and kept dry to prevent infection.
Burn rats were randomly assigned to different treatment groups via
tail vein injection: hUCMSC-exosome group, injectionwith 800 μg (RNA
concentration) hUCMSC-exosomes suspended in 1 ml PBS; hSFC-
exosome group, 800 μg injection of hSFC-exosomes suspended in 1 ml
PBS; miR-181c-pretreated hUCMSC-exosome group, 800 μg hUCMSC-
exosomes transfected with miR-181c suspended in 1 ml PBS; negative
control pretreated hUCMSC-exosomes, 800 μg hUCMSC-exosomes
transfected with negative control suspended in 1 ml PBS. Sham group
rats were placed in water at 37 °C for 12 s and subjected to the samesion in severe burn rats. Samples collected from rats from different groups or cultured cells
R4 expression and its downstream target proteins NF-κB/P65, p-P65 in cutaneouswounds
are. (B). Quantitative analysis of relative TLR4 mRNA expression in cutaneous wounds of
treatment. (C). MiRNA array comparing the relative miR-181c level in cutaneous wounds
81c expression in cutaneous wounds of sham and severe burn rats treated with hUCMSC-
or each treatment. (E). miR-181c levels in hUCMSCs, hUCMSC-exosomes, hSFCs and hSFC-
h treatment.
Fig. 4. hUCMSC-exosomes suppressed the LPS-stimulated inﬂammatory response in macrophages. Mouse RAW264.7 macrophages were cocultured in normal medium or medium
containing hUCMSC-exosomes, hSFC-exosomes, or PBS for 6 h, and the cells were then treated with or without 100 ng/ml LPS for the indicated times. Cell supernatant and cells were
collected after LPS stimulation. (A). Total protein was extracted from cell samples, and after quantitative analysis, equal protein samples were subjected to western blot assay. And the
relative protein level of TLR4 is quantiﬁed using Image J software. (B–C). Quantitative analysis of relative TLR4 levels (B) and miR-181c levels (C) in macrophages after the indicated
treatment for 24 or 48 h. Data are shown as mean ± SD, n = 5 for each treatment. (D–E). ELISA analysis for TNF-α, IL-1β and IL-10 levels in macrophage supernatants after the
indicated treatment for 24 h. Data are shown as mean ± SD, n = 5 for each treatment.
76 X. Li et al. / EBioMedicine 8 (2016) 72–82processes as those applied to the burned rats. Wounds were left open
and animals were sacriﬁced at 24 or 48 h after administration.2.7. Administration of Macrophages with hUCMSC-exosomes or siRNA
Transfection
To knockdown TLR4 gene expression, oligonucleotides (5′-CTGCTG
GATGGTAAATCAT-3′) speciﬁc to mouse TLR4 mRNA (siTLR4) or non-
sense oligonucleotides (5′-TTCTCCGAACGTGTCACGT-3′) were inserted
into the multiple cloning sites of the GV248 vector using restriction en-
donuclease AngI and EcoRI. Mouse RAW264.7 cells were purchased
from Peking Union Medical College and seeded in 6-well plate with
serum-free medium. Upon reaching 60–70% conﬂuence, cells were
transfected with siRNA speciﬁc to mouse TLR4 or nonsense plasmid
using Lipofectamine™ 2000 reagent as previously described (Yu et al.,
2014), or administered with 500 μg (RNA concentration) hUCMSC-Fig. 5.MiR-181c in hUCMSC-exosomes mediated the alleviation of TLR4 signaling in severe
exosomes, miR-181C-exosomes, miR-NC-exosomes or PBS. Rats were sacriﬁced, and serum an
for relative miR-181c expression in hUCMSCs transfected with miR-181c. Data are shown as m
with hUCMSC-exosomes, miR-181C-exosomes, miR-NC-exosomes or PBS. Data are shown a
levels (C) and miR-181c levels (D) in cutaneous wounds from severe burn rats after intrave
24 h. Data are shown as mean ± SD, n = 6 for each treatment. (E). Western blot assay for
wounds from severe burn rats after the indicated treatment for 24 h. And the relative protein
1β (G) and IL-10 (H) serum levels in severe burn rats after 24 h. Data are shown as mean ±
stain) and positive MPO and CD68 staining of cutaneous wounds after the indicated treatmentexosomes suspended in 500 μl PBS, 500 μg hUCMSC-miR-181c-
exosomes suspended in 500 μl PBS or 500 μg hUCMSC-NC-exosomes
suspended in 500 μl PBS. After treatment for 6 h, cells were stimulated
with LPS (100 ng/ml) for 24 h, and cells and media were collected for
further analysis.2.8. Measurement of Inﬂammatory Factors
Plasma samples were obtained from rats at different time points
after burn injury. Cell culture medium samples were collected from
RAW264.7 cells at 24 or 48 h after treatment. The levels of TNF-a
(ab46070 for rat, ab100474 for mouse), IL-1β (ab100768 for rat,
ab100704 for mouse), and IL-10 (ab100765 for rat, ab46103 for
mouse) were detected by a multidetection microplate reader using a
double-antibody sandwich ELISA kit (Abcam, Cambridge, MA, USA) ac-
cording to the manufacturer's protocols.burn rats. 30% TBSA full-thickness burn rats were intravenously injected with hUCMSC-
d skin wound tissues were collected 24 h after administration. (A). Quantitative analysis
ean ± SD, n = 3. (B). Total WBCs in severe burn rats were detected 24 h after treatment
s mean ± SD, n = 6 for each treatment. (C–D). Quantitative analysis for relative TLR4
nous injection of hUCMSC-exosomes, miR-181C-exosomes, miR-NC-exosomes or PBS at
TLR4 expression and downstream target proteins NF-κB/P65, and p-P65 in cutaneous
level of TLR4 is quantiﬁed using Image J software. (F–H). ELISA analysis of TNF-α (F), IL-
SD, n = 6 for each treatment. (I). Representative histological micrograph analysis (HE
for 24 h. And the quantitive assay is done using Image Pro Plus software.
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Histological analyses were performed as described previously (Liu
et al., 2014). The specimens were embedded in parafﬁn after ﬁxation
with 4% paraformaldehyde. Preparative sections were stained with
hematoxylin-eosin (HE) staining for light microscopy. Other sections
were incubated with speciﬁc antibodies against CD-68, or MPO (Santa
Cruz Biotechnology, Santa Cruz, CA), CD-68- and MPO-positive inﬂam-
matory cells in the wounds were counted in 5 randomly selected ﬁelds
on each slide.
2.10. Western Blotting Analysis
Western blotting was performed as described previously. Brieﬂy, total
protein was extracted from RAW264.7 cells and skin tissue samples. Pro-
tein was quantiﬁed using a commercial bicinchoninic acid (BCA) kit
(BCA Protein Assay Kit; Pierce Biotechnology Inc., Rockford, IL, USA).
Equal amounts of protein were separated by SDS-PAGE gel. Antibodies
speciﬁc to TLR4 (ab22048), NF-κB/P65 (ab16502), phospho-P65
(ab86299), and GAPDH (ab9485) were purchased from Abcam (Cam-
bridge, MA, USA). Target proteins were detected using an enhanced
chemiluminescence kit (AmershamPharmacia Biotech, Uppsala, Sweden).
2.11. Real-time PCR Detection
Total RNA was extracted from RAW264.7 cells and rat skin tissues.
Real-time PCR was used to compare the relative expression levels of
TLR4 mRNA by SYBR Green I system. TaqMan miRNA assays (Applied
Biosystems Inc., Carlsbad, CA, USA) were used to quantify miR-181c ex-
pression levels according to the manufacturer's protocol. Primer se-
quences were as follows: rat TLR4 (forward: 5′-GATGATGCCTCTCTTG
CATC-3′; reverse: 5′-GGATTCAAGCTTCCTGGTCT-3′), mouse TLR4 (for-
ward: 5′- TCATGGCACTGTTCTTCTCC-3′; reverse: 5′- TCATCAGGGACT
TTGCTGAG-3′), rat GAPDH (forward: 5′-CAACTCCCTCAAGATTGTCAGC
AA-3′; reverse: 5′-GGCATGGACTGTGGTCATGA-3′), mouse GAPDH (for-
ward: 5′-GGGTGTGAACCATGAGAAGT-3′; reverse: 5′-GACTGTGGTCAT
GAGTCCT-3′), miR-181c (forward: 5′-ATGGTTCGTGCGAACATTCAACCT
GTCGG-3′; reverse: 5′-GCAGGGTCCGAGGTATTC-3′) and U6 (forward:
5′-GCTTCGGCAGCACATATACTAAAAT-3′; reverse: 5′-CGCTTCACGAAT
TTGCGTGTCAT-3′). All data measurements were performed to obtain a
mean CT value for each sample. The CT values of the different samples
were compared using the 2−ΔΔCT method.
2.12. Flow Cytometry for hUCMSCs Identiﬁcation.
The hUCMSCs were seeded to 6-well plate and cultured for 48 h.
After trypsinization, the cells were collected and incubated with anti-
bodies against FITC-CD44 (ab6124), FITC-CD90 (ab23894), FITC-
CD105 (ab44967), FITC-HLA-I (ab23840), FITC-CD31 (ab27333), FITC-
CD34 (ab18227), FITC-CD45 (ab10559), and PE-HLA-DR (ab95830) at
37 °C for 30 min from light, respectively. Then the cells were collected
after centrifugation and washed twice using PBS. The ﬂuorescence was
assessed by ﬂow cytometry (FC500; Beckman Coulter, Brea, CA, USA).
2.13. Statistical Analysis
All data were analyzed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA).
The differences were considered statistically signiﬁcant at p b 0.05.Fig. 6. hUCMSC-exosome-derived miRNA-181c targets TLR4 signaling to inhibit LPS-induced i
miR-181c-exosomes, miR-NC-exosomes and PBS or transfected with siTLR4 or nonsense. Cells
were collected. (A). Western blot assay for TLR4 expression and downstream target proteins N
of TLR4 is quantiﬁed using Image J software. (B–C). Quantitative analysis for relative TLR4 lev
mean ± SD, n = 5 for each treatment. (D). Representative immunoﬂuorescence images of
analysis for TNF-α (E), IL-1β (F) and IL-10 (G) in the supernatant of macrophages after the ind3. Results
3.1. Characterization of hUCMSC-exosomes
Exosomes are small phospholipid bilayer vesicles ranging in size
from 30–100 nm, and they exert various biological functions. hUCMSCs
were cultured and identiﬁed using ﬂow cytometry assay. As shown in
Fig. S1 in the online version at http://dx.doi.org/10.1016/j.ebiom.2016.
04.030, the surface markers, CD44, CD90, CD105, and HLA-I, were ob-
served. And the expressions of CD34, CD45, CD31, and HLA-DR were
negative. To explore the effect of hUCMSC-exosomes on the burn-
induced inﬂammatory response, we isolated exosomes from hUCMSC
supernatant. We conﬁrmed that we indeed isolated exosomes using
several methods. Firstly, we used transmission electron microscopy to
measure the size of hUCMSC-exosomes. hUCMSC-derived exosomes
were round vesicles and ranged in size from 30 to 100 nm (Fig. 1A).
We next used dynamic light scattering to accuratelymeasure the diam-
eter distribution of hUCMSC-exosomes. As shown in Fig. 1B, the diame-
ter of isolated exosomes ranged from30 to 100nm,with a single peak at
approximately 60 nm. Finally, we subjected an RNA ladder and
exosomal RNA to agarose gel electrophoresis. Ribosomal RNA, which
was abundant in mammalian cells, was not present in hUCMSC-
exosomes, though they were rich in small RNAs (Fig. 1C, left panel).
We conﬁrmed these results by Agilent 2100 Bioanalyzer analysis
(Fig. 1C, right panel). And the markers of exosomes, CD9 and CD63,
were also detected by western blot, the results showed that CD9 and
CD63 were rich in exosome samples (Fig. 1D). Taken together, the re-
sults indicated that the isolated hUCMSC-exosome fraction was pure
and could be used for subsequent experiments.3.2. hUCMSC-exosomes Alleviated the Inﬂammatory Response of Rats after
Burn Injury
To meet the strict diagnosis criteria and to serve as a tool to investi-
gate the potential of therapeutics, we established a stable and optimized
rat model with 30% TBSA full-thickness burn injury, which induces an
excessive inﬂammatory response. Compared to the sham group, the
total white blood cell count was signiﬁcantly higher in burn rats
(Fig. 2A). Interestingly, hUCMSC-exosome administration dramatically
reduced the number of total white blood cells induced by burn injury,
especially after 24 h (Fig. 2A). hSFC-exosomes were used as a negative
control, as their administration alone had no effect on the amount of
white blood cells after burn injury (Fig. 2A). We examined the inﬂam-
matory factors present in rat serum using ELISA assay and found that
TNF-a (Fig. 2B) and IL-1β levels (Fig. 2C) remarkably increased after
burn injury compared to the sham group. Treatment with hUCMSC-
exosomes successfully reduced their levels. Interestingly, the anti-
inﬂammatory factor IL-10 was signiﬁcantly increased in the hUCMSC-
exosome administration groups at 24 h (Fig. 2D). Histological evalua-
tion of cutaneous wounds collected from different groups at 24 h re-
vealed that the number of inﬂammatory cells in burn rats, such as
neutrophils (MPO) and macrophages (CD68) were markedly higher
than the sham group. hUCMSC-exosome administration signiﬁcantly
reduced the number of neutrophils (MPO) and macrophages (CD68)
compared to the burn group (Fig. 2E, left panel). And quantative analy-
sis was also done using Image Pro Plus software (Fig. 2E, right panel). In
general, hUCMSC-exosome administration signiﬁcantly suppressed in-
ﬂammation after burn injury.nﬂammation. Mouse RAW264.7 macrophages were cocultured with hUCMSC-exosomes,
were treated with or without 100 ng/ml LPS for 24 h, and the cell supernatant and cells
F-κB/P65 and p-P65 after the indicated treatment for 24 h. And the relative protein level
els (B) and miR-181c levels (C) after the indicated treatment for 24 h. Data are shown as
TLR4 expression in macrophages after the indicated treatment for 24 h. (E–G). ELISA
icated treatment for 24 h. Data are shown as mean ± SD, n = 5 for each treatment.
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Cutaneous Wound of Severe Burn Rats
The TLR4 signaling pathway is one of the most important regulators
of the inﬂammatory reaction. To conﬁrm the role of hUCMSC-exosomes
in inhibiting inﬂammation, we examined TLR4 expression and its
downstream target proteins NF-κB/P65, and p-P65 in the cutaneous
wound of rats after different treatments. Compared with the sham
group, TLR4, NF-κB/P65 and p-P65 protein levels were signiﬁcantly in-
creased in burn rats, and hUCMSC-exosome administration signiﬁcantly
downregulated TLR4, NF-κB/P65 and p-P65 protein expression, espe-
cially at 24 h. hSFC-exosomes had no effect on TLR4, NF-κB/P65 and p-
P65 protein expression after burn injury (Fig. 3A, upper panel). And
the consistent result was gained after quantiﬁcation of relative TLR4
protein level (Fig. 3A, lower panel). We also examined TLR4 mRNA
levels in cutaneous wound of rats from different groups by RT-PCR
and found that TLR4 mRNA levels (Fig. 3B) increased after burn injury
compared to the sham group, but hUCMSC-exosome administration
did not affect TLR4 mRNA expression. Because hUCMSC-exosomes reg-
ulated TLR4 protein levels but not mRNA levels, we examined potential
mediators of this effect. We compared miRNA expression between se-
vere burn rats and sham rats by miRNA array and found that miR-
181c expression was remarkably lower in burn rats compared to sham
rats (Fig. 3C). Sequence alignment using TargetScan software indicated
that miR-181c could bind to the TLR4 mRNA 3′-untranslational region
(Fig. 3C). The report also demonstrated that miR-181c could bind to
3′-UTR of TLR4 mRNA, and downregulation its protein expression
(Zhang et al., 2015). Furthermore, miR-181c was upregulated in the cu-
taneous wound of hUCMSC-exosome administration group, especially
at 24 h (Fig. 3D). To conﬁrm the active component of hUCMSC-
exosomes in anti-inﬂammation, we compared miR-181c expression in
hUCMSCs, hUCMSC-exosomes, hSFCs and hSFC-exosomes. miR-181c
expression was remarkably higher in the hUCMSC-exosome group
compared to the hSFC-exosome group (Fig. 3E). Taken together, these
data suggest that hUCMSC-exosome administration signiﬁcantly in-
creased miR-181c expression in cutaneous wounds, which might con-
tribute to regulation of TLR4 protein translation.3.4. hUCMSC-exosomes Suppressed LPS-induced Macrophage Inﬂammation
To identify the mechanisms by which hUCMSC-exosomes exerted
anti-inﬂammatory effects, we used LPS-stimulated macrophages as an
inﬂammatory cell model. Compared to the in control group, TLR4, NF-
κB/P65 and p-P65 protein levels were signiﬁcantly higher in LPS-
stimulated macrophages, and hUCMSC-exosome administration signif-
icantly downregulated LPS-induced TLR4, NF-κB/P65 and p-P65 protein
expression, especially at 24 h (Fig. 4A, upper panel). Compared to
hUCMSC-exosomes, hSFC-exosomes had no effect on inﬂammatory
protein levels after LPS stimulation (Fig. 4A, upper panel). The
quantative data also showed that hUCMSC-exosome administration sig-
niﬁcantly reduced the protein level of TLR4 (Fig. 4A, lower panel). As
in vivo, RT-PCR analysis also showed that TLR4mRNA levels (Fig. 4B) in-
creased after LPS stimulation compared to the control group, while
hUCMSC-exosome administration had no effect on TLR4 mRNA expres-
sion. Similarly, miR-181c levels were upregulated in LPS-stimulated
macrophages after hUCMSC-exosome administration, especially at
24 h (Fig. 4C).We performed ELISA assays to examine the inﬂammatory
factors in the supernatant of culturedmacrophages. The results demon-
strated that TNF-a (Fig. 4D) and IL-1β levels (Fig. 4E) signiﬁcantly in-
creased after LPS stimulation compared to the control group, and
hUCMSC-exosomes successfully decreased their levels. Consistent
with the in vivo results, IL-10 levels notably increased in the hUCMSC-
exosome administration groups after 24 h (Fig. 4F). The above results
demonstrated that hUCMSC-exosomes suppressed LPS-inducedmacro-
phage inﬂammation.3.5. MiR-181c Inhibited TLR4 Expression and Suppressed the Inﬂammatory
Reaction
The above results suggested that miR-181c is involved in the
regulation of burn-induced inﬂammation. To verify the relationship
between the inﬂammatory response and miR-181c expression,
we injected severe burn rats with exosomes derived from miR-
181c- or miR-NC-transfected hUCMSCs. We transfected hUCMSCs
with miR-181c or miR-NC and conﬁrmed that miR-181c levels
increased upon miR-181c transfection (Fig. 5A). We then compared
the anti-inﬂammatory function of the miR-181c-exosome adminis-
tration group and the hUCMSC-exosome administration group and
found that miR-181c-exosome administration dramatically
decreased total white blood cell count 24 h after severe burn injury
compared to the hUCMSC-exosome group (Fig. 5B). RT-PCR analysis
showed that TLR4 mRNA levels were not signiﬁcantly different
between the groups (Fig. 5C), but miR-181c levels were obviously
increased in the cutaneous wound of the miR-181c-exosome admin-
istration group at 24 h (Fig. 5D). TLR4, NF-κB/P65 and p-P65 protein
levels were signiﬁcantly decreased in the miR-181c-exosome
administration group at 24 h compared to the hUCMSC-exosome
administration group (Fig. 5E, upper panel), and quantative analysis
of TLR4 protein level was also done using Image J software (Fig. 5E,
lower panel). We also examined the inﬂammatory factors in the
serum from the indicated groups by ELISA assay and found that
TNF-a (Fig. 5F) and IL-1β levels (Fig. 5G) signiﬁcantly decreased in
the miR-181c-exosome administration group. Furthermore, IL-10
levels were higher in the miR-181c-exosome administration group
at 24 h (Fig. 5H). We also performed histological evaluation of
cutaneous wounds from different groups at 24 h. The number of in-
ﬂammatory cells in the miR-181c-exosome administration groups,
including neutrophils (MPO) and macrophages (CD68), were mark-
edly lower than that in the hUCMSC-exosome administration group
(Fig. 5I, left panel). And quantative analysis was also done using
Image Pro Plus software (Fig. 5I, right panel). In general, miR-181c-
exosome administration notably inhibited inﬂammation after burn
injury. These data suggest that miR-181c plays a critical role in
regulating burn-induced inﬂammation by downregulating TLR4
protein expression.
3.6. hUCMSC-exosome-derived miR-181c Restricted LPS-induced Inﬂam-
mation by Targeting TLR4
To explore the mechanism by which hUCMSC-exosome-derived
miR-181c suppressed inﬂammation, we treated macrophages with
exosomes derived from miR-181- or miR-NC-transfected hUCMSCs, or
transfected macrophages with TLR4 or nonsense siRNA. After 6 h, we
treated cells with LPS. Consistent with our in vivo results, TLR4, NF-
κB/P65 and p-P65 protein expression was signiﬁcantly downregulated
in the miR-181c-exosome group and TLR4 siRNA group at 24 h com-
pared to hUCMSC-exosome administration (Fig. 6A, upper panel). And
the consistent result was gained after quantiﬁcation of relative TLR4
protein level (Fig. 6A, lower panel). RT-PCR analysis also showed that
miR-181c-exosome administration had no effect on TLR4 mRNA ex-
pression, which was signiﬁcantly decreased in TLR4 siRNA-transfected
macrophages (Fig. 6B). miR-181c levels were notably upregulated in
LPS-stimulated macrophages in the miR-181c-exosome administration
group and TLR4 siRNA group at 24 h (Fig. 6C). To observe the inﬂuence
of exosomes and siRNA on TLR4 expression, we performed immunoﬂu-
orescent staining to detect surface TLR4 expression by macrophages
after multiple treatments. We found that compared to the control
group, TLR4 expression signiﬁcantly increased after LPS exposure, and
miR-181c-exosome administration or TLR4 siRNA transfection dramat-
ically reduced TLR4 expression ELISA assay revealed that macrophages
secreted signiﬁcantly lower levels of TNF-a (Fig. 6E) and IL-1β
(Fig. 6F) after miR-181c-exosome or TLR4 siRNA administration
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TLR4 administration successfully increased IL-10 levels at 24 h
(Fig. 6G). These results suggested that miR-181c inhibited LPS-
induced inﬂammation by downregulating TLR4 pathway activation.
4. Discussion
Recent studies have demonstrated that hUCMSC administration can
reduce inﬂammation in many disease models. hUCMSCs signiﬁcantly
reduced systemic inﬂammation and attenuated LPS-induced acute
lung injury in rats (Li et al., 2012), reduced inﬂammatory cytokine pro-
duction and regulated the balance of the coagulation and
anticoagulation system to cure immune-related thrombophilia (Lin
et al., 2012), and inhibited IFN-γ expression and IL-17 production by
lamina propria mononuclear cells (LPMCs) in colitic mice (Liang et al.,
2011).
Interestingly, MSCs have been found to secrete exosomes, which are
enriched in the extracellular environment. Exosomes have been consid-
ered vital mediators of cellular communication and may regulate vari-
ous physiological and pathological processes by transferring
membrane proteins, mRNAs, and miRNAs to recipient cells (Hu et al.,
2012; Hoshino et al., 2013; Kowal et al., 2014). Recent studies have
demonstrated that exosomes can act at different stages of the inﬂam-
matory response by transporting bioactive factors, and MSC-exosomes
have reported to suppress inﬂammation in different animal models
(Choi et al., 2014; Zhuet al., 2014;Monsel et al., 2015). Zhu YG et al. con-
ﬁrmed that MSC-released microvesicles reduced extravascular lung
water, neutrophil inﬂux andmacrophage inﬂammatory protein-2 levels
in the bronchoalveolar lavage (BAL) ﬂuid in an acute lung injury mouse
model, partly through KGFmRNA expression (Zhu et al., 2014). There is
limited knowledge on the role of hUCMSC-exosomes in severe burn-
induced excessive inﬂammation.
Excessive inﬂammation is an early systemic inﬂammatory response
that can result in multiple organ failure and even death (Leclerc et al.,
2011). miRNAs enriched in exosomes play a pivotal role in regulating
inﬂammation (Wang et al., 2015). miR-155 and miR-146a are two crit-
ical regulators of inﬂammation, as exosomal miR-146a administration
represses inﬂammatory gene expression and reduces endotoxin-
induced inﬂammation in mice (Alexander et al., 2015). miR-181c abro-
gates TLR4 expression by directly binding to its 3′-UTR to restrict the in-
ﬂammatory response (Zhang et al., 2015).
Our study demonstrated a signiﬁcant beneﬁcial effect from
hUCMSC-exosome administration on severe burn-induced excessive in-
ﬂammation. We found that hUCMSC-exosomes reduced the number of
total white blood cells and downregulated TLR4, NF-κB/P65 and p-P65
protein expression, which prevented the release of inﬂammatory fac-
tors such as IL-1β and TNF-α. The therapeutic effects of hUCMSC-
exosome administration in our study were achieved through tail vein
injection, suggesting that the homing characteristic of hUCMSC-
exosomes may help them reach the site of inﬂammation.
TLR4 is a key protein that has been reported to play an important
role in inﬂammation (Ping et al., 2012). Since TLR4 was identiﬁed as
the LPS receptor, it has been suggested to trigger all LPS responses,
and macrophage is key causative participants in this process
(Plociennikowska et al., 2015). Previous studies have shown that TLR4
expression in activatedmicroglia mediates neuroinﬂammation through
nuclear factor-κB (NF-κB) in response to brain injury (Mao et al., 2012).
The NF-κB family consists of ﬁve members, including p105/p50, p100/
p52, p65/Rel A, Rel B and c-Rel (Yu et al., 2009). In silent cells, NF-κB
is kept inactive by binding to IκB proteins. Upon LPS stimulation, IκB
proteins are targeted for degradation by the 26S proteasome after IκB
kinase (IKK) phosphorylation (Yu et al., 2009). p65 can then translocate
into the nucleus and initiate inﬂammatory gene expression.
Additionally, we demonstrated that through inﬂammatory signal-
ing, the TLR4 receptor regulates miR-181 and that reduced miR-181
levels after severe burn-induced excessive inﬂammation may be apro-survival mechanism. The results of our study showed that after se-
vere burn or LPS stimulation of macrophages, hUCMSC-exosome or
miR-181c-exosome administration successfully restricted TLR4 expres-
sion, which may subsequently reduce p65 phosphorylation to regulate
inﬂammatory factor expression.
Hutchison ER et al. previously showed that miR-181 knockdown en-
hanced LPS-induced production of TNF-a, IL-6, IL-1β, IL-8 and HMGB1,
while miR-181 overexpression resulted in a signiﬁcant increase in
anti-inﬂammatory cytokine IL-10 expression in the neuroinﬂammatory
responses of astrocytes (Hutchison et al., 2013). In the serum of severe
burn rats, hUCMSC-exosomes suppressed TNF-α and IL-1β secretion
and increased IL-10 secretion. IL-10 is considered an anti-
inﬂammatory cytokine, and a previous study found that macrophage-
derived IL-10 is necessary for the effect of BMSCs in mouse sepsis
models (Nemeth et al., 2009). In mouse macrophage cell line cultures,
hUCMSC-exosomes downregulated TNF-α and IL-1β levels and upregu-
lated IL-10 levels after LPS stimulation, suggesting an immunomodula-
tory effect in animal models similar to cultured cells. However,
hUCMSC-exosomes do not affect the expression of TNF-α, IL-1β and
IL-10 after 24 h, suggesting that a second dose may be necessary in
the burn rat models in future studies.
In summary, our study elucidated the importance of the mechanism
by which miR-181c regulates burn-induced inﬂammation. hUCMSC-
exosome-derived miR-181c decreased TLR4 expression and subse-
quently reduced NF-κB/p65 activation, which was an important media-
tor in regulating inﬂammatory factor expression and restricting burn-
induced inﬂammation in rats. Therefore, we have deﬁned a critical
role for exosomal miR-181c in regulating burn-induced inﬂammation
and provided a potential target for clinical therapy of burn patients.
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